Crestchem Limited (BOM:526269)
124.35
-1.50 (-1.19%)
At close: Aug 21, 2026
Crestchem Revenue
Crestchem had revenue of 94.53M INR in the quarter ending June 30, 2026, with 87.90% growth. This brings the company's revenue in the last twelve months to 340.29M, up 36.87% year-over-year. In the fiscal year ending March 31, 2026, Crestchem had annual revenue of 296.07M with 18.07% growth.
Revenue (ttm)
340.29M
Revenue Growth
+36.87%
P/S Ratio
1.10
Revenue / Employee
67.67M
Employees
5
Market Cap
373.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 296.07M | 45.30M | 18.07% |
| Mar 31, 2025 | 250.77M | 38.21M | 17.98% |
| Mar 31, 2024 | 212.56M | 45.28M | 27.07% |
| Mar 31, 2023 | 167.28M | 87.81M | 110.49% |
| Mar 31, 2022 | 79.47M | 3.06M | 4.00% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Tyche Industries | 500.33M |
| Vasundhara Rasayans | 347.79M |
| Link Pharma Chem | 283.85M |
| Krebs Biochemicals & Industries | 252.34M |
| Ishita Drugs and Industries | 124.05M |